Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways. 2016

Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.

Accumulating evidence suggests that activation of microglia plays a key role in the pathogenesis of depression. Activated microglia produce a wide range of factors whose prolonged or excessive release may lead to brain disorders. Thus, the inhibition of microglial cells may be beneficial in the treatment of depressive diseases. Tianeptine is an atypical antidepressant drug with proven clinical efficacy, but its mechanism of action remains still not fully understood. In the present study, using microglial cultures we investigated whether tianeptine modifies microglial activation after lipopolysaccharide (LPS) stimulation and which intracellular pathways are involved in the activity of this antidepressant. Our study shows that tianeptine attenuated the LPS-evoked inflammatory activation of microglia by decreasing the expression of proinflammatory cytokines such as IL-1β, IL-18, IL-6 and tumor necrosis factor α (TNF-α), the release of nitric oxide (NO) and reactive oxygen species (ROS) as well as the expression of inducible nitric oxide synthase. Analyses of signaling pathways demonstrate that tianeptine led to the suppression of LPS-induced TLR4 expression and ERK1/2 phosphorylation. Furthermore, our study reveals the inhibitory impact of tianeptine on caspase-3-induced PKCδ degradation and consequently on the activation of NF-κB factor in microglial cells. Taken together, present results show anti-inflammatory properties of tianeptine in microglial cultures stimulated by LPS. This study provides evidence that the inhibition of microglial activation may underlie the therapeutic activity of tianeptine. Our findings show the anti-inflammatory effect of tianeptine (TIA) in lipopolisaccharide (LPS)-stimulated microglial cells. The beneficial tianeptine action is mediated through the inhibition of Toll-like receptor 4 (TLR4) expression as well as the TLR4-related pathways: extracellular signal-regulated kinase 1/2 (ERK1/2), caspase-3-dependent protein kinase δ (PKCδ) cleavage and the expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). These findings may provide a new therapeutic strategy for treatment of disorders based on neuroinflammation, including depression.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013841 Thiazepines Compounds that are derivatives of THIEPINS, with a nitrogen replacing a carbon in the seven-membered heterocyclic compound. Thiazepine
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
September 2017, Journal of neurochemistry,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
March 2013, Experimental and therapeutic medicine,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
January 2019, Frontiers in immunology,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
September 2023, The journal of trauma and acute care surgery,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
June 2023, Discovery medicine,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
January 2016, PloS one,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
June 2010, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
September 2017, International immunopharmacology,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
November 2008, Journal of neuroimmunology,
Joanna Slusarczyk, and Ewa Trojan, and Katarzyna Glombik, and Anna Piotrowska, and Boguslawa Budziszewska, and Marta Kubera, and Katarzyna Popiolek-Barczyk, and Wladyslaw Lason, and Joanna Mika, and Agnieszka Basta-Kaim
May 2014, International journal of molecular medicine,
Copied contents to your clipboard!